PhyMed  PHYMED
DIAGNOSTIC IMAGING CENTER
 


EXAMINATION DATE:
10/16/2000


STEVE PERKINS MD
5939 HARRY HINES BLDG. 2 SUITE
DALLAS, TX 75235

PATIENT: FURLONG,  NEILA ACCOUNT#: 107501
DOB:    1941-06-01
EXAM:    M R I    BRAIN    W & W/O CONTRAST


TECHNIQUE:

This 184-slice MRI scan of the brain was performed in the following sequences:

Pre-Contrast
1.   Sagittal T1-weighted 5mm thickness.
2.   Axial T1-weighted 5 mm thickness.
3.   Axial T2-weighted 5 mm thickness.
4.   Axial FLAIR 5 mm thickness.
5.   Coronal FLAIR 5 mm thickness.

Post-Constrast:
1.   Axial T1-weighted 5 mm thickness.
2.   Coronal t1-weighted 5 mm thickness.


FINDINGS:

There are extensive coalescent areas of increased signal on T1 and T2-weighted images in the periventricular white matter and centrum semiovale occupying almost the entirety of the white matter tracts.  There are also small and punctate areas of increased signal in the basal ganglia, thalamic nuclei and midbrain.  The ventricles and cisternal spaces are prominent and compatible with cerebral atrophy.  There are no areas of abnormal enhancement to suggest active metastatic disease.  The above is nonspecific but most compatible with post radiation gliosis.  The bony clavarium and skull bse is intact.


IMPRESSION:

1.    Extensive gliosis in the periventricular white matter, with cerebral atrophy.  There are also abnormal areas of increased signal in the basal ganglia, thalamic nuclei and midbrain. Given prior history of metastatic disease to the brain and radiation therapy, this likely is secondary to radiation and/or chemotherapeutic gliosis.  Lact of contrast enhancement mitigates against active metastasis.


STEVEN STEINBAUM, M.D.
Neuroradiologist

SS:jlg

D:  10/16/00
T:  10/16/00

PATIENT:   FURLONG,  NEILA
PATIENT: FURLONG,  NEILA ACCOUNT#: 107501
Page 2 of 2